Therapeutic Asset Ratings

303 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
mln9708 Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue	University of Washington	P2	CCC (53)
mln9708 Waldenstrom Macroglobulinemia	University of Washington	P2	CCC (53)
Odronextamab High Grade B-Cell Lymphoma	University of Washington	P2	CCC (53)
Odronextamab Primary Mediastinal Large B-Cell Lymphoma	University of Washington	P2	CCC (53)
Pacritinib Acute Myeloid Leukemia	University of Washington	P2	CCC (53)
PAN-FGFR TYROSINE KINASE INHIBITOR JNJ-42756493 Prostate Carcinoma	University of Washington	P2	CCC (53)
PEGASPARGASE Recurrent B Lymphoblastic Lymphoma	University of Washington	P2	CCC (53)
PEGASPARGASE Refractory B Lymphoblastic Lymphoma	University of Washington	P2	CCC (53)
PEGFILGRASTIM B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1	University of Washington	P2	CCC (53)
PEGFILGRASTIM B-Lymphoblastic Leukemia/Lymphoma With T(9;22)(Q34.1;Q11.2)	University of Washington	P2	CCC (53)
Ponatinib B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1	University of Washington	P2	CCC (53)
Ruxolitinib Myeloproliferative Neoplasm, Unclassifiable	University of Washington	P2	CCC (53)
SRY-BOX TRANSCRIPTION FACTOR 2 Non-Small Cell Lung Carcinoma	University of Washington	P2	CCC (53)
SRY-BOX TRANSCRIPTION FACTOR 2 Hormone Receptor-Positive Breast Cancer	University of Washington	P2	CCC (53)
SRY-BOX TRANSCRIPTION FACTOR 2 Triple-Negative Breast Carcinoma	University of Washington	P2	CCC (53)
SRY-BOX TRANSCRIPTION FACTOR 2 Lung Cancer	University of Washington	P2	CCC (53)
SX682 Non-Small Cell Lung Carcinoma	University of Washington	P2	CCC (53)
SX682 Metastatic Lung Non-Small Cell Carcinoma	University of Washington	P2	CCC (53)
SX682 Lung Cancer	University of Washington	P2	CCC (53)
SX682 Stage IV Lung Cancer AJCC v8	University of Washington	P2	CCC (53)
Tafasitamab B-Cell Acute Lymphoblastic Leukemia	University of Washington	P2	CCC (53)
VIPIVOTIDE TETRAXETAN GALLIUM GA-68 Prostate Adenocarcinoma	University of Washington	P2	CCC (53)
Yb-1 Non-Small Cell Lung Carcinoma	University of Washington	P2	CCC (53)
Yb-1 Hormone Receptor-Positive Breast Cancer	University of Washington	P2	CCC (53)
Yb-1 Triple-Negative Breast Carcinoma	University of Washington	P2	CCC (53)

Showing 201 to 225 of 303 assets

PreviousPage 9 of 13Next